Testing commissioned by NOW Foods evaluated twelve creatine gummy products. Five were reported as severely understrength — 41.7%, or about 42%. One product claiming 5 g per serving was reported at 0.005 g. The results show why brands should verify the test method, production lot and shelf-life support before launch.
Creatine is unusually difficult to carry in a gummy for both physical and chemical reasons.
A 5 g dose is enormous relative to a gummy. A typical functional gummy weighs 4–5 g per piece. Delivering 5 g of a single active across a three-piece serving means the active accounts for roughly 35–40% of total mass. Most gummy lines are built for actives measured in milligrams, not grams — vitamins, minerals, botanical extracts. Loading a formula to 40% active changes the physics of the entire process.
Three things break as load increases:
Creatine monohydrate is a crystalline powder that does not dissolve well at the temperatures and water activity levels a gummy slurry runs at. As inclusion rises, the slurry thickens and behaves less predictably through the depositing head. Deposit weights start to vary piece to piece. If the line is not compensating, some gummies carry more active than others — and a potency test on a random sample reflects that spread.
Undissolved crystalline material in the matrix produces a gritty or chalky mouthfeel. This shows up directly in consumer reviews, and it is the constraint that pushes many brands to reduce their dose rather than fix the process. It is also why several brands on the market sit at 3–3.5 g per serving instead of the 5 g clinical reference.
Creatine monohydrate can convert to creatinine in solution, with conversion accelerated by lower pH and higher temperature. In a gummy project, the relevant risks are heat and moisture exposure during manufacturing, followed by long-term storage in a mildly acidic matrix. Release testing alone cannot establish a 24-month shelf life.
Common possibilities that a brand's quality team should investigate include:
Most of these failures are detectable during supplier evaluation, if you ask for the right things. A certificate on its own proves very little.
A meaningful third-party report carries a sample code, a batch number, a report date and an issuing laboratory. Those four fields let you connect the number to a physical lot. A document that says "creatine gummies — pass" with no traceable identifiers connects to nothing.
For reference, records retained on our own evaluated samples read: 34.6% active content, sample code 727-2026-00005570, batch 25031201, reported 19 March 2026; and 36.2%, sample code BSFE2501139-001, batch 25031201, reported 20 March 2026. Whether you work with us or not, that is the level of specificity worth insisting on.
The single most useful question in supplier evaluation: what changes between the sample I approve and the first commercial batch? A manufacturer running pilot validation before scale will have a direct answer. One that does not will talk about experience and certifications instead.
Request the stability protocol and available results, not only release data. Accelerated studies help identify risk earlier, while ongoing real-time data are needed to support the full claimed shelf life.
If a retailer or a third-party tester finds your product understrength, the recall, the delisting and the reputational damage land on your brand, not on the factory. Contract language rarely changes that. Verification before you order is the only real protection.
A related and less discussed issue: how many gummies a consumer has to eat to reach the dose. Products on the market currently range from roughly 1.0 g to 1.9 g of creatine per piece. At the low end a consumer needs four or five gummies per serving, which shortens the bottle, raises cost per serving and shows up in reviews.
Higher density is a manufacturing capability question, not a formulation preference. It requires a process that can hold high active load without the viscosity and texture problems described above.
Creatine gummies fail potency testing because a 5 g dose sits at the edge of what the gummy format can carry, and because the gap between an approved sample and a production batch often goes unverified. Both are addressable. Neither is addressed by a certificate with no sample code on it.
If you are scoping a creatine gummy project, the creatine specification page lists what we hold and how it is verified.
This article discusses supplier-evaluation principles and publicly reported market testing. It does not allege that any named brand intentionally misstated potency.
In testing commissioned by NOW Foods, 5 of 12 creatine gummy products were reported as severely understrength. That is 41.7%, or about 42%.
Creatine monohydrate can convert to creatinine in solution, with faster conversion at lower pH and higher temperature. Manufacturing heat exposure, moisture and an acidic gummy matrix therefore need to be considered in process and stability studies.
Ask for traceable third-party reports, production-lot testing, and a stability program that includes accelerated data and ongoing real-time data supporting the claimed shelf life.
Send your target dose, format and volume. Our New York team confirms feasibility before quoting — MOQ 5,000 bottles, samples in 7–14 days.
Request a QuoteWhat minimum order quantities, sample timelines and production lead times to expect from a private label gummy manufactu…
Read article →A practical comparison of pectin and gelatin gummy bases for supplement brands — texture, heat resistance, dietary posit…
Read article →